Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: One-Year Results of a Prospective Single Institution Initiative.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 21 03 2022
revised: 21 04 2022
accepted: 07 05 2022
pubmed: 2 6 2022
medline: 17 8 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Although mentorship has been associated with promotion, job satisfaction, and retention, data are limited on the mentorship experience of clinical- versus research-track physicians as well as feasibility and relative priority of formal program components. Within a single-institution, multi-site, academic network, we implemented a Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for junior faculty. Validated surveys assessing mentee satisfaction were distributed at baseline and 1 year. The statistical analysis included Wilcoxon rank sum and signed tests. Mentees assessed the likelihood to recommend each program component (10-point Likert-type scale), and means with standard error (SE) are reported. Among 42 eligible junior faculty, 36 (86%) opted into the program. The median time since residency was 2.5 years (interquartile range, 1.75-5.25) on the clinical track (n = 12) and 3 years (interquartile range, 2.75-5.00) on the research track (n = 24). At baseline, research-track physicians reported higher satisfaction with mentoring than physicians on the clinical track (2.92 vs 2.16; P = .02). Among 32 physicians completing 1 year, overall satisfaction with mentoring increased compared with baseline (2.72 vs 3.87; P < .001), which persisted on subset analysis for both clinical- (2.16 vs 4.03; P < .001) and research-track physicians (2.99 vs 3.77; P = .005). At 1 year, 28 mentees (88%) opted to continue the program. Program components were rated 8.25 (SE, 0.37) for mentor-mentee pairings, 7.22 (SE, 0.39) for goal setting, 6.84 (SE, 0.47) for administrative support, 6.69 (SE, 0.44) for peer mentoring, and 6.53 (SE, 0.45) for steering committee oversight. Ratings of peer mentoring were not associated with track (P = .59) or years in practice (P = .29). Clinical-track physicians may be less satisfied with mentorship than research-track faculty. However, all junior faculty, regardless of track, appeared to benefit from formalizing dyadic mentor-mentee relationships, goal setting, and peer mentoring. Further work is needed to determine the role of mentorship in addressing physician burnout.

Identifiants

pubmed: 35644504
pii: S0360-3016(22)00420-5
doi: 10.1016/j.ijrobp.2022.05.012
pmc: PMC9396442
mid: NIHMS1822505
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-29

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Références

Ann Surg Oncol. 2021 Oct;28(11):6051-6057
pubmed: 33876361
JAMA. 2006 Sep 6;296(9):1103-15
pubmed: 16954490
PLoS One. 2018 Nov 29;13(11):e0207634
pubmed: 30496199
Arch Intern Med. 2009 May 25;169(10):990-5
pubmed: 19468093
Am J Med. 2002 Mar;112(4):336-41
pubmed: 11893387
Clin Teach. 2018 Jun;15(3):197-202
pubmed: 29318730
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):732-740
pubmed: 29893281
Acad Med. 2013 Jul;88(7):1029-37
pubmed: 23702518
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):421-429
pubmed: 32890525
Acad Med. 2004 Oct;79(10 Suppl):S9-11
pubmed: 15383376
Med Teach. 2014 Jul;36(7):608-14
pubmed: 24804918
J Gen Intern Med. 2007 Feb;22(2):210-4
pubmed: 17356988
J Gen Intern Med. 2021 Oct;36(10):3113-3121
pubmed: 33846943
Acad Med. 1998 Mar;73(3):318-23
pubmed: 9526459
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):292-302
pubmed: 33412265
Acad Med. 2014 May;89(5):774-82
pubmed: 24667509
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):18-24
pubmed: 24210670
Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):610-618
pubmed: 34157364
J Gen Intern Med. 2005 Sep;20(9):866-70
pubmed: 16117759
Am J Obstet Gynecol. 2004 Dec;191(6):1846-50
pubmed: 15592263
Science. 2006 Jan 27;311(5760):473-4
pubmed: 16439648
Radiother Oncol. 2021 Sep;162:119-123
pubmed: 34256081

Auteurs

Diana Lin (D)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Daniel R Gomez (DR)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Yue Helen Zhang (YH)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Renee Gennarelli (R)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York.

Jason A Efstathiou (JA)

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Chris A Barker (CA)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Daphna Y Gelblum (DY)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Monika K Shah (MK)

Office of the Deputy Physician-in-Chief, Education and Faculty Affairs, Memorial Sloan Kettering Cancer Center, New York, New York.

Laura Liberman (L)

Office of the Deputy Physician-in-Chief, Education and Faculty Affairs, Memorial Sloan Kettering Cancer Center, New York, New York.

Ariel E Hirsch (AE)

Department of Radiation Oncology, Boston University, Boston, Massachusetts.

Oren Cahlon (O)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Erin F Gillespie (EF)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York; Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: efgillespie@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH